SCNLF
Price:
$0.1305
Market Cap:
$107.83M
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company deve...[Read more]
Industry
Biotechnology
IPO Date
2013-08-02
Stock Exchange
OTC
Ticker
SCNLF
According to Scancell Holdings plc’s latest financial reports and current stock price. The company's current ROE is 166.42%. This represents a change of 92.23% compared to the average of 86.57% of the last 4 quarters.
The mean historical ROE of Scancell Holdings plc over the last ten years is -11.98%. The current 166.42% ROE has changed -1489.33% with respect to the historical average. Over the past ten years (40 quarters), SCNLF's ROE was at its highest in in the April 2023 quarter at 140.70%. The ROE was at its lowest in in the April 2021 quarter at -59.64%.
Average
-11.98%
Median
-32.92%
Minimum
-202.37%
Maximum
191.50%
Discovering the peaks and valleys of Scancell Holdings plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 243.16%
Maximum Annual ROE = 191.50%
Minimum Annual Increase = -1906.93%
Minimum Annual ROE = -202.37%
Year | ROE | Change |
---|---|---|
2024 | 167.16% | -12.71% |
2023 | 191.50% | -1906.93% |
2022 | -10.60% | -94.76% |
2021 | -202.37% | 243.16% |
2020 | -58.97% | -2.16% |
2019 | -60.27% | 100.32% |
2018 | -30.09% | -44.84% |
2017 | -54.54% | 110.98% |
2016 | -25.85% | -27.69% |
2015 | -35.75% | 45.99% |
The current ROE of Scancell Holdings plc (SCNLF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
116.02%
5-year avg
17.34%
10-year avg
-11.98%
Scancell Holdings plc’s ROE is greater than Anavex Life Sciences Corp. (-31.21%), greater than Annovis Bio, Inc. (-188096.33%), greater than Iovance Biotherapeutics, Inc. (-49.71%), greater than Axsome Therapeutics, Inc. (-363.79%), greater than Novavax, Inc. (-115.51%),
Company | ROE | Market cap |
---|---|---|
-31.21% | $869.94M | |
-188096.33% | $49.30M | |
-49.71% | $591.06M | |
-363.79% | $5.34B | |
-115.51% | $1.14B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scancell Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Scancell Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Scancell Holdings plc's ROE?
How is the ROE calculated for Scancell Holdings plc (SCNLF)?
What is the highest ROE for Scancell Holdings plc (SCNLF)?
What is the 3-year average ROE for Scancell Holdings plc (SCNLF)?
What is the 5-year average ROE for Scancell Holdings plc (SCNLF)?
How does the current ROE for Scancell Holdings plc (SCNLF) compare to its historical average?